May 19th CEU – School-based Management  of cCMV Children

Delaware Speech-Language-Hearing Association Presents
A Virtual Evening Meeting: Tuesday May 19 th 2026, 6:30pm- 8:00pm

Course title:  School-based Management  of cCMV Children

Presenter and credentials:   Kathleen J Riley, AuD, CCC-A, CH-EdAuD  Educational
Audiologist

Speaker bio: Dr. Kathleen Riley (Kathi Riley) is an educational audiologist with over 40
years experience. Kathi retired from Delaware School for the Deaf and Statewide
Programs for Deaf, Hard of Hearing and Deaf Blind in 2017.  In that position she served
0-21 DHH, DeafBlind and Deaf with additional challenges children in both a residential
school and mainstream students in their home districts.  Additionally, Dr Riley taught
coursework in AuD and SLP programs at the graduate and undergraduate level for 10
years.  Currently, Kathi serves as President -Elect for EAA.   Previously, she served as
the VP of Advocacy for the Educational Audiology Association where she led a team to
write best practice guidance documents for educational audiologists.  Within that role,
Dr Riley has been involved in numerous ad hoc committees through EAA and ASHA to
promote educational audiology services and erase access barriers for children with
hearing differences. Kathi Riley was a founding member of the DE EHDI committee and
continues to serve as a public member after retirement.   Dr. Riley has long been
interested in congenital cytomegalovirus (cCMV) in children with disabilities as it
presents uniquely in every affected child.  It is the second leading cause of hearing loss
in children and the leading cause of delayed onset pediatric hearing loss.  She has
presented at ASHA 2025 on this topic, as well as a recorded webinar for ASHA
Learning Pass.  Dr. Riley continues to follow updated research on this topic and is
passionate about spreading fact-based knowledge about cCMV.  Of particular interest,
is the under identification of cCMV children, the need for universal newborn screening
and awareness of CMV among school based providers.
Financial and non-financial disclosures:

Course description:  This course explores the transmission and consequences of
congenital cytomegalovirus in children, which include hearing differences,
speech/language delays and disorders, social emotional development, behavior
challenges, autism and intellectual delays.  A review of current data and vaccine
development will be reviewed.  Risk reduction strategies for SLPs and other related
service providers will be explained.  Myths and misconceptions about cCMV as well as
IDEA and FERPA/HIPAA will be discussed.

Course instructional level:  Intermediate

Instructional methods: Lecture, powerpoint, discussion

Learning objectives: 
Explain the impacts of CMV and how it is transmitted

Use risk reduction strategies to decrease the likelihood of the spread of CMV in the
school setting

Analyze student behaviors and challenges within the context of possible undiagnosed
CMV

Create public awareness of cCMV among all school professionals, and advocate at the
state and federal level for universal screening of all newborns

Time ordered agenda:  
Introduction to the mechanisms and transmission of cCMV 10 minutes
Prevalence, testing, and vaccine development   10 minutes
Recent research on child development impacts  10 minutes
Risk reduction strategies for children and staff  5 minutes
Assessment, IEP development  5 minutes
Legislation efforts for universal screening/CMV awareness  5 minutes
Discussion, Question and Answer  15 minutes

Registration & Satisfactory Completion Requirement:
Register online by Sunday May 10 th at 12pm: https://dsha.org/events
Members should login before attempting to register.
Cost: Members= Free , Non-Members=35$
A link will be sent to registered attendees only, the day before the event.

In order to earn a certificate of completion for this course, participants must attend the
full session, complete a post-course self-assessment, and course evaluation.
Participants must indicate when signing up for the course if they would like their
participation reported to ASHA CE.
Partial credit will not be awarded, attendance will be monitored throughout the
presentation.

A post-test will be sent to all attendees following the event and must be

completed and returned to DSHA within the stated time frame in order to receive
a certificate of attendance.
Additionally, in order to receive a certificate of attendance, an attendee must be a
registered DSHA member or, pay the non-member registration fee in advance of
the event. Failure to meet one of these conditions will result in the attendee not
receiving their certificate of attendance and their attendance will not be reported
to ASHA.

1.5 PDHs will be offered for attendance and successful completion of post
presentation testing and evaluation.